Restoring FDA’s Premarket Review Powers
Scholar proposes reforms to address deficiencies in FDA’s premarket review powers.
Increasing Transparency in the Biologic Patent Dance
Scholars propose changes to patent disclosures under the Biologics Price Competition and Innovation Act.
Congratulating TRR’s 2024-2025 Editorial Board
The Regulatory Review extends its gratitude to the publication’s graduating leadership and team members.
Climate Resilience Requires Digital Justice
Equal access to technology is a necessary but overlooked part of responsible environmental regulation.
Regulating in the Name of Public Health
Mitch Zeller discusses the challenges of regulating to protect the public’s best interest.
What Does the CFPB’s Mass Guidance Withdrawal Mean? Not Much
A federal consumer protection agency’s withdrawal of numerous guidance documents will have little legal effect.
Week in Review
President Trump issues orders to limit criminal regulatory offenses and lower prescription drug costs, and more…
Repealing Without Procedure
Executive orders to repeal rules and redefine “showerhead” contain a jarring assertion of presidential authority.
Multi-Level Marketing, Multi-Level Accountability
Scholar urges lawmakers to hold multi-level marketing companies liable for misleading claims made by salespeople.
A Global Approach to Artificial Intelligence
UN advisory body evaluates opportunities for the international regulation of artificial intelligence.
Storytelling, Rulemaking, and de Tocqueville
Receiving stories in agency rulemakings is integral to American democracy.
Is it Time to Reform a Landmark U.S. Environmental Law?
Experts debate reforming the National Environmental Policy Act.